Experiments for taxon Kadsura heteroclita (SCHISANDRACEAE)

Experiments (81 results)

Filters
Worktypes (18)
31
28
19
17
17
16
15
11
9
9
5
4
3
3
3
2
1
1
No match
Pharmacology (10)
24
4
4
3
2
2
2
1
1
38
No match
Compounds (28)
6
6
6
5
5
5
5
5
4
4
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
13
No match
Organisms (15)
33
8
7
7
4
4
3
3
2
2
2
2
2
1
1
No match
81 experiments
No experiment matches the selected filters.
ExperimentWorktypesPharmacologyOrganism (specimen)Compound
134729
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN G
1322683
MEDICINAL FOLKLORE REPORTED FOR
ANTIINFLAMMATORY ACTIVITY
Kadsura heteroclita (SCHISANDRACEAE)
577375
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Kadsura heteroclita (SCHISANDRACEAE)
LANOSTA-4(30)-9(11)-13(18)-CIS-24-TETRAEN-3-26-DIOIC ACID,14-(13-12)-ABEO: 3-4-SECO:
444446
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Kadsura heteroclita (SCHISANDRACEAE)
LANOSTA-9(11)-CIS-24-DIEN-26-OIC ACID,12(S)-ACETOXY-3-OXO:
130789
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDVOUCHER SPECIMEN REPORTED FORCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN A
101867
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Kadsura heteroclita (SCHISANDRACEAE)
KADSURANIC ACID A,SECO-NEO:
974132
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Kadsura heteroclita (SCHISANDRACEAE)
904092
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Kadsura heteroclita (SCHISANDRACEAE)
COCCINIC ACID,12-ALPHA-ACETOXY:
444448
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Kadsura heteroclita (SCHISANDRACEAE)
LANOSTA-9(11)-CIS-24-DIEN-26-OIC ACID,12(R)-ACETOXY-3-OXO:
134744
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
INTERIORIN
134733
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN A
1324578
MEDICINAL FOLKLORE REPORTED FOR
ANALGESIC ACTIVITY
Kadsura heteroclita (SCHISANDRACEAE)
101868
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Kadsura heteroclita (SCHISANDRACEAE)
LANOSTA-4(30)-8-24-TRIENE-3-26-DIOIC ACID,3-4-SECO: (24-CIS):
134722
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN F
974137
PHARMACOLOGY OF COMPOUND - IN VIVO
GLUTATHIONE DEPLETION
Kadsura heteroclita (SCHISANDRACEAE)
KADSURIN
130791
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN C
134750
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN E
134752
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN E
577376
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CHOLESTEROL INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
LANOSTA-4(30)-9(11)-13(18)-CIS-24-TETRAEN-3-26-DIOIC ACID,14-(13-12)-ABEO: 3-4-SECO:
101872
CMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Kadsura heteroclita (SCHISANDRACEAE)
LANOSTA-8-24-DIEN-26-OIC ACID,3-OXO: (24-CIS):
134728
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN G
130793
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN E
974135
PHARMACOLOGY OF COMPOUND - IN VIVO
SUPEROXIDE DISMUTASE STIMULATION
Kadsura heteroclita (SCHISANDRACEAE)
KADSURIN
134739
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN C
444451
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CHOLESTEROL SYNTHESIS INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
LANOSTA-4(30)-8-CIS-24-TRIENE-3-26-DIOIC ACID,3-4-SECO:
134741
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN C
134723
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN F
1322690
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Kadsura heteroclita (SCHISANDRACEAE)
134734
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN B
942098
PATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Kadsura heteroclita (SCHISANDRACEAE)
LANOSTA-9(11)-CIS-24-DIEN-26-OIC ACID,12(S)-ACETOXY-3-OXO:
942100
ISOLATION AND IDENTIFICATION OF
Kadsura heteroclita (SCHISANDRACEAE)
LANOSTA-9(11)-CIS-24-DIEN-26-OIC ACID,12(R)-ACETOXY-3-OXO:
134747
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN D
974136
PHARMACOLOGY OF COMPOUND - IN VIVO
ANTIHEPATOTOXIC ACTIVITY
Kadsura heteroclita (SCHISANDRACEAE)
KADSURIN
134736
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN B
1050281
IDENTIFICATION IN BY HPLC
Kadsura heteroclita (SCHISANDRACEAE)
SCHISANTHERIN CSCHISANTHERIN ASCHISANTHERIN B
134745
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
INTERIORIN
101869
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Kadsura heteroclita (SCHISANDRACEAE)
KADSURANIC ACID A,NEO:
134730
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN A
1322684
PHARMACOLOGY OF EXTRACT - IN VIVOVOUCHER SPECIMEN REPORTED FOR
TOXIC EFFECT(UNSPEC)
Kadsura heteroclita (SCHISANDRACEAE)
1324491
MEDICINAL FOLKLORE REPORTED FOR
ANALGESIC ACTIVITY
Kadsura heteroclita (SCHISANDRACEAE)
134725
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN F
904091
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Kadsura heteroclita (SCHISANDRACEAE)
COCCINIC ACID,12-BETA-HYDROXY:
113233
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Kadsura heteroclita (SCHISANDRACEAE)
SITOSTEROL,BETA:
974134
ISOLATION AND IDENTIFICATION OF
Kadsura heteroclita (SCHISANDRACEAE)
KADSURIN
1322688
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Kadsura heteroclita (SCHISANDRACEAE)
101871
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTUREINFRARED SPECTRUM REPORTED FOR
Kadsura heteroclita (SCHISANDRACEAE)
KADSURANIC ACID A,NEO:
134727
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN G
130792
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN D
134738
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN C
355698
UV SPECTRUM GIVEN FORIDENTIFICATION IN BY HPLCHPLC SEPARATION DATA FOR
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN DHETEROCLITIN GKADSURININTERIORIN
942099
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CHOLESTEROL SYNTHESIS INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
LANOSTA-9(11)-CIS-24-DIEN-26-OIC ACID,12(S)-ACETOXY-3-OXO:
134748
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN D
444450
QUANTITATIVE DATAPATENT DESCRIBEDISOLATION AND IDENTIFICATION OF
Kadsura heteroclita (SCHISANDRACEAE)
LANOSTA-4(30)-8-CIS-24-TRIENE-3-26-DIOIC ACID,3-4-SECO:
134724
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN F
134753
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN E
904090
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Kadsura heteroclita (SCHISANDRACEAE)
COCCINIC ACID,12-BETA-ACETOXY:
974130
VOUCHER SPECIMEN REPORTED FOR
Kadsura heteroclita (SCHISANDRACEAE)
904093
PMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Kadsura heteroclita (SCHISANDRACEAE)
COCCINIC ACID,12-ALPHA-HYDROXY:
134742
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Kadsura heteroclita (SCHISANDRACEAE)
INTERIORIN
134735
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN B
1322685
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Kadsura heteroclita (SCHISANDRACEAE)
134746
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN D
134731
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN A
134737
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN B
134749
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN D
1322689
PHARMACOLOGY OF EXTRACT - IN VIVO
ANTIINFLAMMATORY ACTIVITY
Kadsura heteroclita (SCHISANDRACEAE)
134726
UV SPECTRUM GIVEN FORX-RAY CHRYSTALLOGRAPHIC STUDIESPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN G
130795
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATACD SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Kadsura heteroclita (SCHISANDRACEAE)
INTERIORIN
113232
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURECD SPECTRUM REPORTED FORINFRARED SPECTRUM REPORTED FOR
Kadsura heteroclita (SCHISANDRACEAE)
KADSULACTONE A
974133
PHARMACOLOGY OF EXTRACT - IN VIVO
GLUTATHIONE DEPLETION
Kadsura heteroclita (SCHISANDRACEAE)
134732
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN A
974131
PHARMACOLOGY OF EXTRACT - IN VIVO
SUPEROXIDE DISMUTASE STIMULATION
Kadsura heteroclita (SCHISANDRACEAE)
130790
UV SPECTRUM GIVEN FORPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN B
134743
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
INTERIORIN
134754
ISOLATION AND IDENTIFICATION OF
Kadsura heteroclita (SCHISANDRACEAE)
SITOSTEROL,BETA:SITOSTEN-3-ONE,BETA:
101870
QUANTITATIVE DATAISOLATION AND IDENTIFICATION OF
Kadsura heteroclita (SCHISANDRACEAE)
LANOSTA-8-24-DIEN-26-OIC ACID,3-OXO: (24-CIS):
134740
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN C
444447
PHARMACOLOGY OF COMPOUND - IN VITROPATENT DESCRIBED
CHOLESTEROL SYNTHESIS INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
LANOSTA-9(11)-CIS-24-DIEN-26-OIC ACID,12(S)-ACETOXY-3-OXO:
130794
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDMASS-SPECTRAL FRAGMENTATION REPORTEDQUANTITATIVE DATACD SPECTRUM REPORTED FORISOLATION AND IDENTIFICATION OF
Kadsura heteroclita (SCHISANDRACEAE)
KADSURIN
134751
PHARMACOLOGY OF COMPOUND - IN VITRO
LIPID PEROXIDE FORMATION INHIBITION
Kadsura heteroclita (SCHISANDRACEAE)
HETEROCLITIN E
1322686
PHARMACOLOGY OF EXTRACT - IN VIVO
ANALGESIC ACTIVITY
Kadsura heteroclita (SCHISANDRACEAE)